ArticleCureus2025
Distal Femoral Replacement for Fragility and Periprosthetic Fractures in a District General Hospital: A Five-Year Retrospective Cohort Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Distal femur fractures in elderly or comorbid patients pose a significant challenge due to poor bone stock, complex fracture morphology, and limited tolerance for prolonged immobility. Distal femoral replacement (DFR) is increasingly utilised as an alternative to internal fixation, but evidence for its use outside tertiary centres remains limited. Methods We retrospectively reviewed all DFR procedures for trauma indications at a district general hospital (DGH) over a five-year period (2019-2024). Patient demographics, perioperative variables, infection rates, transfusion requirements, length of stay, and mortality were analysed. Results Twenty-four patients underwent DFR for non-oncological trauma, including native and periprosthetic distal femoral fractures. Surgical site infections (SSIs) occurred in 25% (n = 6) of cases, with 16.7% superficial and 8.3% deep infections. Median time to surgery was three days. A total of 83.3% of patients required blood transfusions. Median length of stay was 17.5 days. One-year mortality was 16.7%, and 90-day mortality was 8.3%. All discharged patients returned to their own homes. Conclusion DFR can be safely delivered in a DGH setting with infection and mortality rates comparable to published data from tertiary centres. Early surgery and full weight-bearing rehabilitation are achievable and may contribute to functional recovery in this vulnerable cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.